Upcoming Virtual and In-Person Educational Events for Patients and Medical Professionals ➜ VIEW NOW

Announcing Our New Partnership

Eric D. Gordon, M.D.

Medical Director – Gordon Medical Associates
Consulting Expert and Medical Research in Chronic Illness

In addition to 40 + years of clinical practice, Dr. Gordon is engaged in clinical research. In 2007-2009, he created a series of medical symposia, bringing together leading international medical researchers and cutting-edge clinicians focusing on ME/CFS, Lyme disease, autoimmune diseases and autism. He has worked with Dr. Robert Naviaux, who has done ground breaking research into metabolomics, mitochondrial function, and chronic inflammatory disease. In 2016 Dr. Gordon was co-author with Dr. Naviaux on a groundbreaking study, “Metabolic Features of Chronic Fatigue Syndrome”, published in the Proceedings of the National Academy of Science (PNAS).

My deep respect for the individuality of my patients is the heart of my practice. The point is to carefully listen to each patient and correlate their subjective experience with pertinent objective laboratory tests, to determine unique treatment guidelines that allow the innate wisdom of the body to overcome illness and restore good health.

Education & Credentials | Publications | Press | Media

Education

Albany Medical College, Albany NY (MD)

Queens College (B.A. Chemistry)

Residency

St. Clare's Hospital, Schenectady, NY

Professional Memberships

American Board of Family Practice 1984-2004

American College of Advancement in Medicine (ACAM) 1995-2009

International Lyme and Associated Diseases Society (ILADS) 2005-2022

Orthomolecular Health Medicine (OHM) 1998-2009

Member of Board of Directors of Orthomolecular Health Medicine (OHM) 2009 

President: Science in Service of Humanity – 2012 – present

President: Gordon Medical Research Center – 2016 – present

Diplomate Member of International Society for Environmentally Acquired Illness (ISEAI) - 2019 – present

American Academy of Stem Cell Physicians (AASCP)2019 - present 

International Peptide Society 2021

"Metabolic features of chronic fatigue syndrome"
Robert K. Naviaux, Jane C. Naviaux, Kefeng Li, A. Taylor Bright, William A. Alaynick, Lin Wang, Asha Baxter, Neil Nathan, Wayne Anderson, Eric Gordon Proceedings of the National Academy of Sciences,  Sep 2016, 113 (37) E5472-E5480; DOI: 10.1073/pnas.1607571113

“Lyme Complex: Taxonomy and Treatment,” Gordon, E., Anderson, W., and Fass, N., Townsend Letter, July 2013

"Nanotechnology's latest oncolytic agent: silver, cancer, & infection associations", Townsend Letter, May 2006.

Areas of Practice

  • Complex Chronic Illness
  • ME/CFS – Chronic Fatigue Syndrome
  • Tick Borne Disease/Lyme Disease
  • Mold/Mycotoxins
  • Autoimmune Illness
  • Mast Cell Activation Syndrome (MCAS)
  • Environmental Illness
  • Fibromyalgia
  • Functional Medicine
  • Cell Danger Response
  • Metabolomics Research
  • Patient Care
  • Case Review
  • Consults
  • Clinical Research
  • Speaker
  • Educator

The Cell Danger Response and the Healing Cycle in Chronic Illness

Inflammation is the body’s normal response to danger. The body’s inflammatory response is meant to be transient – when that response is ongoing, and especially when the inciting event (pathogens, toxic elements) persists, the normal tamping down of inflammation doesn’t occur. When inflammation persists and the Healing Cycle is not completed the clinical presentation is an outcome of their genetic tendencies. – Naviaux RK. – Metabolic features of the cell danger response.

Looking for what is broken is no longer the answer.

Patients we see have dysfunction, but they are not broken. Conventional medicine, what Bob Naviaux calls the First Book of Medicine, is great for when you are broken; an accident, a broken bone, an acute infection. For patients with chronic illness, looking for what is broken is no longer the answer. For them, we have to start creating the Second Book of Medicine. This is where the concepts of functional medicine are brought to life.

"Metabolic features of chronic fatigue syndrome"

Robert K. Naviaux, Jane C. Naviaux, Kefeng Li, A. Taylor Bright, William A. Alaynick, Lin Wang, Asha Baxter, Neil Nathan, Wayne Anderson, Eric Gordon Proceedings of the National Academy of Sciences,  Sep 2016, 113 (37) E5472-E5480; DOI: 10.1073/pnas.1607571113

“Lyme Complex: Taxonomy and Treatment,” Gordon, E., Anderson, W., and Fass, N., Townsend Letter, July 2013

"Nanotechnology's latest oncolytic agent: silver, cancer, & infection associations", Townsend Letter, May 2006.

“Scientists find signature of Chronic Fatigue Syndrome in blood which suggests disease is the body going into hibernation”, Telegraph Reporters, The Telegraph, August 30, 2016

“Blood simple?”, The Economist, September 1, 2016

“Naviaux’s Metabolism Paper Is About As Big As You Think”, Seltzer, Jaime, #ME Action, August 30, 2016

“Chronic fatigue syndrome may be a human version of ‘hibernation”, Cha, Ariana Eunjung, Washington Post, September 6, 2016

“Santa Rosa doctor’s study offers new insight into chronic fatigue syndrome,” Kovner, Guy, Press Democrat, September 21, 2016

“Metabolomic Deficiencies Characteristic of Chronic Fatigue Syndrome”, Lampner, Cindy, Clinical Pain Advisor, November 10, 2016